Related Experiment Video
Updated: Feb 19, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Developing and implementing a family-led infection prevention bundle for hospitalized neonates
Chimwemwe Viola Tembo1,2, Kwana Lechiile3,4, Boingotlo Gopolang3
1Botswana-University of Pennsylvania Partnership, Gaborone, Botswana. violatembo@yahoo.co.uk.
Background:
For many neonatal units in resource-limited settings, family involvement in patient care is both a logistic necessity and a cultural norm. However, incorporating families into hospital infection prevention and control (IPC) activities remains under-implemented and under-studied. We developed a family-led infection prevention (FLIP) bundle for a neonatal unit in Botswana and evaluated its impact on multidrug-resistant organism (MDRO) colonization, bloodstream infection (BSI) incidence, and all-cause mortality.
Methods:
The FLIP bundle was developed with input from a multidisciplinary group of stakeholders including subject matter experts, staff, and families. The bundle components consisted of staff-led family orientation on (1) hand hygiene, (2) twice-weekly neonatal skin cleansing with 2% aqueous chlorhexidine gluconate, (3) lactation support, and (4) skin-to-skin contact. The bundle was implemented over 18 months (August 2023-January 2025) at a 33-bed neonatal unit in Botswana during which time it was iteratively revised based on process metric performance. MDRO colonization was assessed twice-monthly using perirectal and skin swabs to detect extended-spectrum cephalosporin-resistant and carbapenem-resistant Enterobacterales and Acinetobacter spp. BSI incidence was determined from growth on neonatal blood cultures, excluding contaminants. In-hospital mortality data were extracted from hospital records. Colonization, BSI, and mortality rates were compared before and after pilot and continuation phases using two-proportion z-tests and Chi-square tests.
Results:
Implementation of the FLIP bundle was temporally associated with a significant relative reduction in all-cause mortality by 28% across the unit, decreasing from 15.4% (165/1069) pre-FLIP to 11.1% (208/1866) during FLIP (p < 0.001). BSI incidence decreased modestly from 11.3% (121/1069) to 9.7% (181/1866) during FLIP (p = 0.14). MDRO colonization trends showed mixed results, with initial improvements to Acinetobacter spp. colonization but an overall 9.4% increase in skin MDRO colonization observed (p < 0.001) in the implementation period.
Conclusion:
Implementation of the FLIP bundle demonstrated the potential of systematically engaging families in neonatal IPC programs, with a notable improvement in infant survival observed. The lack of clear improvement in BSI incidence and MDRO colonization prevalence may reflect incomplete adoption or poor impact of the bundle and highlights that FLIP should be used in conjunction with robust healthcare worker-led IPC measures.
More Related Videos
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

